top of page

COVID-19 Latest News

Updated: Sep 8, 2021

The novel coronavirus (SARS-CoV-2) pandemic (COVID-19) is a rapidly evolving situation and affecting now over 170 countries. To understand the facts and remove the myths and manage the threat of continued SARS-CoV-2 infection and the risk to public health lets put our strengths together to fight this. For this we provide you with the essential resources and updated information and guidance from WHO, CDC and professional sites like ours. We will continue to post more related scientific papers over the coming weeks as they become available.

APAAACI joins the COVID-19 Recommendations and Gateway to Contextualization

The COVID19 Recommendations and Gateway to Contextualization collects trustworthy recommendations on COVID-19 for clinical, public health and health policy. It allows decision-makers to identify relevant recommendations for their question of interest. APAAACI has joined COVID-19 Evidence Prime as a partner. Read More

Trending News:

Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk

Why You Should Not Use Ivermectin to Treat or Prevent COVID-19

COVID vaccines protect against Delta, but their effectiveness wanes

COVID-19 Vaccines for Moderately to Severely Immunocompromised People

Interim Guidelines for COVID-19 Antibody Testing

They Had Mild Covid. Then Their Serious Symptoms Kicked In.

The way in which the new COVID-19 variants transmit hasn’t changed


What should you expect after getting a COVID-19 vaccine?


How does WHO assess safety of COVID-19 vaccines?


Exclusive Webinar Pre-Recorded Viewing:

Topic: PSAAI Press Conference on Allergies and COVID-19 Vaccines: A Heart to Heart Talk

Date: Feb 11, 2021

Shared recording (Accessible with passcode: 8!xNasOL)

Dr. Fauci: The U.S. Will Remain a Member of the World Health Organization


COVID Vaccine Conspiracies With Dr. Fauci


Dr Katie Allen - Allergist, MP & Important Member of APAAACI - Covid Vaccine Alert



More News:

COVID-19 Weekly Cases and Deaths per 100,000 Population by Age, Race/Ethnicity, and Sex

Interim Public Health Recommendations for Fully Vaccinated People

FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine

From paper to digital pathway: WHO launches first ‘SMART Guidelines’

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States

ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paper

Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US

Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys

COVID-19 Vaccines and Allergic Reactions

COVAX publishes first interim distribution forecast

Emergence of SARS-CoV-2 B.1.1.7 Lineage — United States

Australian COVID-19 vaccine rollout brought forward two weeks to early March

COVID-19 Vaccines: Current Status and Implication for Use in Indonesia

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine

EMA recommends first COVID-19 vaccine for authorisation in the EU

Pfizer-BioNTech COVID-19 Vaccine

This scientist’s decades of mRNA research led to both COVID-19 vaccines

Centers for Disease Control and Prevention - Vaccines (Update)


International Resource Sites:

World Health Organization (WHO):

Centers for Disease Control and Prevention (CDC):

U.S. Food & Drug Administration (FDA):

Gavi The Vaccine Alliance:

384 views2 comments

Recent Posts

See All
bottom of page